Atlas Trials

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Clinical trial NCT06856135 · AVAILABLE

Trial details

NCT number
NCT06856135
Sponsor
Takeda
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Crohn's DiseaseUlcerative Colitis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.